The story of Viagra, and its developer copyright, presents a complex case study for investors. At first a blockbuster drug, yielding billions in sales , its patent expiration created a wave of knock-off medications, significantly eroding its market share . While specific businesses may attempt to capitalize on similar conditions , the current lands